These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8400114)

  • 41. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
    Handley DA; Van Valen RG; Melden MK; Houlihan WJ; Saunders RN
    J Pharmacol Exp Ther; 1988 Nov; 247(2):617-23. PubMed ID: 3183958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antagonistic effect of myricetin on platelet activing factor].
    Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
    Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB; Lam MH; Biftu T; Beattie TR; Shen TY
    J Biol Chem; 1985 Dec; 260(29):15639-45. PubMed ID: 2999126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
    Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin.
    Herbert JM; Castro-Faria-Neto HC; Barbosa-Filho JM; Cordeiro RS; Tibiriça E
    J Lipid Mediat Cell Signal; 1997 Sep; 17(1):1-14. PubMed ID: 9302650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.
    Han BH; Yang HO; Kang YH; Suh DY; Go HJ; Song WJ; Kim YC; Park MK
    J Med Chem; 1998 Jul; 41(14):2626-30. PubMed ID: 9651167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
    Hussaini IM; Shen TY
    Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
    Yamada T; Tomioka K; Saito M; Horie M; Mase T; Hara H; Nagaoka H
    Arch Int Pharmacodyn Ther; 1990; 308():123-36. PubMed ID: 2099131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Octylonium bromide interacts competitively with the PAF receptor.
    Barone D; Maggi CA; Baroldi P; Giachetti A; Meli A
    Drugs Exp Clin Res; 1989; 15(8):363-7. PubMed ID: 2557193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
    Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
    Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Maffrand JP
    Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes.
    Hwang SB
    Eur J Pharmacol; 1991 Apr; 196(2):169-75. PubMed ID: 1651872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle.
    Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL
    Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    Hwang SB
    J Biol Chem; 1988 Mar; 263(7):3225-33. PubMed ID: 2830276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.